Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linker

Showing results (821-830 of 860) with videos related to

Pageof 86
Sort By:
Acta Neuropathologica Communications|May 9, 2023
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastomaAyse N Menevse, Laura-Marie Ammer, Arabel Vollmann-Zwerenz, et al.
Neurological Research and Practice|December 16, 2020
The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trialU Meyding-Lamadé, C Jacobi, F Martinez-Torres, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseasesMuriel Schraad, Mathias Mäurer, Anke Salmen, et al.
Ecological Modelling|October 22, 2021
The Chesapeake Bay Program Modeling System: Overview and Recommendations for Future DevelopmentRaleigh R Hood, Gary W Shenk, Rachel L Dixon, et al.
Nature|June 11, 2025
Attosecond inner-shell lasing at ångström wavelengthsThomas M Linker, Aliaksei Halavanau, Thomas Kroll, et al.
NPJ Parkinson'S Disease|August 10, 2022
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson's disease patientsShani Stern, Shong Lau, Andreea Manole, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2018
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventionsIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 3, 2017
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of responseJan-Patrick Stellmann, Markus Krumbholz, Tim Friede, et al.
Cell|March 12, 2020
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory MechanismAlexander Duscha, Barbara Gisevius, Sarah Hirschberg, et al.
Annals of Neurology|November 6, 2015
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment coursesIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Pageof 86

Showing results (821-830 of 860) with videos related to

Sort By:
Pageof 86
Acta Neuropathologica Communications|May 9, 2023
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastomaAyse N Menevse, Laura-Marie Ammer, Arabel Vollmann-Zwerenz, et al.
Neurological Research and Practice|December 16, 2020
The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trialU Meyding-Lamadé, C Jacobi, F Martinez-Torres, et al.
Therapeutic Advances in Neurological Disorders|December 15, 2025
Cellular and humoral vaccination response under immunotherapies-German consensus on vaccination strategies in neurological autoimmune diseasesMuriel Schraad, Mathias Mäurer, Anke Salmen, et al.
Ecological Modelling|October 22, 2021
The Chesapeake Bay Program Modeling System: Overview and Recommendations for Future DevelopmentRaleigh R Hood, Gary W Shenk, Rachel L Dixon, et al.
Nature|June 11, 2025
Attosecond inner-shell lasing at ångström wavelengthsThomas M Linker, Aliaksei Halavanau, Thomas Kroll, et al.
NPJ Parkinson'S Disease|August 10, 2022
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson's disease patientsShani Stern, Shong Lau, Andreea Manole, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 23, 2018
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventionsIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 3, 2017
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of responseJan-Patrick Stellmann, Markus Krumbholz, Tim Friede, et al.
Cell|March 12, 2020
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory MechanismAlexander Duscha, Barbara Gisevius, Sarah Hirschberg, et al.
Annals of Neurology|November 6, 2015
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment coursesIngo Kleiter, Anna Gahlen, Nadja Borisow, et al.
Pageof 86